Koninklijke DSM N.V. EBIT

Koninklijke DSM N.V. posts a EBIT of $0 as of September 2023. That compares with $660M in the prior-year period — down 100.0% year over year. That is below the Materials sector average of $29B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Koninklijke DSM N.V.'s EBIT was $660M. The latest reading is $0 — a 100.0% year-over-year decrease (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

For Materials stocks, a EBIT near $29B is typical. Koninklijke DSM N.V.'s $0 is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Koninklijke DSM N.V.'s financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for KDSKF's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $29B), and (3) consistency with growth and profitability. This page covers the first two; Koninklijke DSM N.V.'s other metric pages and overview cover the third.